The global market for infection surveillance solutions is set for substantial expansion, with projections estimating an increase from $544.93 million in 2022 to approximately $1,581.37 million by 2031 — a compound annual growth rate (CAGR) of 12.7%. This substantial growth is primarily fueled by the escalating prevalence of hospital-acquired infections (HAIs) and the amplifying integration…